drugset / Trial / NCT01654640

The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine

NCT01654640 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is the evaluation of effect of metformin on obesity and metabolic disturbance in patients taking clozapine.

Timeline

Start
2012-09
Primary completion
2015-04
Completion
2015-04

Outcome

Outcome not reported

Stopped (Enrollment): “Failure to recruit the planned number of participants”

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral

Indications